newsfilter
← Latest News
Business Wire·

Savara To Present New Data at the American Thoracic Society (ATS) 2026 International Conference

-- All Presentations Include New Data from the Phase 3 IMPALA-2 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP), Including Data from the Ongoing